231 related articles for article (PubMed ID: 30307748)
21. Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.
Freedman SB; Xie J; Neufeld MS; Hamilton WL; Hartling L; Tarr PI; ; Nettel-Aguirre A; Chuck A; Lee B; Johnson D; Currie G; Talbot J; Jiang J; Dickinson J; Kellner J; MacDonald J; Svenson L; Chui L; Louie M; Lavoie M; Eltorki M; Vanderkooi O; Tellier R; Ali S; Drews S; Graham T; Pang XL
Clin Infect Dis; 2016 May; 62(10):1251-1258. PubMed ID: 26917812
[TBL] [Abstract][Full Text] [Related]
22. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11.
Misselwitz J; Karch H; Bielazewska M; John U; Ringelmann F; Rönnefarth G; Patzer L
Pediatr Infect Dis J; 2003 Apr; 22(4):349-54. PubMed ID: 12690276
[TBL] [Abstract][Full Text] [Related]
23. Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2.
Ibarra C; Amaral MM; Palermo MS
IUBMB Life; 2013 Oct; 65(10):827-35. PubMed ID: 24014500
[TBL] [Abstract][Full Text] [Related]
24. Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: A population-based matched case control study.
Myojin S; Pak K; Sako M; Kobayashi T; Takahashi T; Sunagawa T; Tsuboi N; Ishikura K; Kubota M; Kubota M; Igarashi T; Morioka I; Miyairi I
PLoS One; 2022; 17(2):e0263349. PubMed ID: 35120154
[TBL] [Abstract][Full Text] [Related]
25. Complement contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome.
Karpman D; Tati R
Kidney Int; 2016 Oct; 90(4):726-9. PubMed ID: 27633864
[TBL] [Abstract][Full Text] [Related]
26. Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.
Peco-Antić A
Srp Arh Celok Lek; 2016; 144(11-12):664-9. PubMed ID: 29659236
[TBL] [Abstract][Full Text] [Related]
27. Shiga Toxin Therapeutics: Beyond Neutralization.
Hall G; Kurosawa S; Stearns-Kurosawa DJ
Toxins (Basel); 2017 Sep; 9(9):. PubMed ID: 28925976
[TBL] [Abstract][Full Text] [Related]
28. Primary Human Derived Blood Outgrowth Endothelial Cells: An Appropriate In Vitro Model to Study Shiga Toxin Mediated Damage of Endothelial Cells.
Feitz WJC; van de Kar NCAJ; Cheong I; van der Velden TJAM; Ortiz-Sandoval CG; Orth-Höller D; van den Heuvel LPJW; Licht C
Toxins (Basel); 2020 Jul; 12(8):. PubMed ID: 32751286
[TBL] [Abstract][Full Text] [Related]
29. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C
Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409
[TBL] [Abstract][Full Text] [Related]
30. Shiga Toxin-Associated Hemolytic Uremic Syndrome in Adults, France, 2009-2017.
Travert B; Dossier A; Jamme M; Cointe A; Delmas Y; Malot S; Wynckel A; Seguin A; Presne C; Hie M; Benhamou Y; Ribes D; Choukroun G; Grangé S; Hertig A; Le Gall EC; Galicier L; Daugas E; Bouadma L; Weill FX; Azoulay E; Fakhouri F; Veyradier A; Bonacorsi S; Hogan J; Frémeaux-Bacchi V; Rondeau E; Mariani-Kurkdjian P; Coppo P;
Emerg Infect Dis; 2021; 27(7):1876-1885. PubMed ID: 34152955
[TBL] [Abstract][Full Text] [Related]
31. Severely ill pediatric patients with Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS) who suffered from multiple organ involvement in the early stage.
Luna M; Kamariski M; Principi I; Bocanegra V; Vallés PG
Pediatr Nephrol; 2021 Jun; 36(6):1499-1509. PubMed ID: 33205220
[TBL] [Abstract][Full Text] [Related]
32. Serogroup-specific bacterial engineered glycoproteins as novel antigenic targets for diagnosis of shiga toxin-producing-escherichia coli-associated hemolytic-uremic syndrome.
Melli LJ; Ciocchini AE; Caillava AJ; Vozza N; Chinen I; Rivas M; Feldman MF; Ugalde JE; Comerci DJ
J Clin Microbiol; 2015 Feb; 53(2):528-38. PubMed ID: 25472487
[TBL] [Abstract][Full Text] [Related]
33. Editorial: Recent Advances in Understanding the Pathogenesis of Shiga Toxin-Producing
Lee MS; Yoon JW; Tesh VL
Front Cell Infect Microbiol; 2020; 10():620703. PubMed ID: 33324585
[No Abstract] [Full Text] [Related]
34. Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activation.
Bowen EE; Hurcombe JA; Barrington F; Keir LS; Farmer LK; Wherlock MD; Ortiz-Sandoval CG; Bruno V; Bohorquez-Hernandez A; Diatlov D; Rostam-Shirazi N; Wells S; Stewart M; Teboul L; Lay AC; Butler MJ; Pope RJP; Larkai EMS; Morgan BP; Moppett J; Satchell SC; Welsh GI; Walker PD; Licht C; Saleem MA; Coward RJM
Med; 2023 Nov; 4(11):761-777.e8. PubMed ID: 37863058
[TBL] [Abstract][Full Text] [Related]
35. Constipation and hemolytic uremic syndrome.
Crawford B; Strebeck P; Saccente S
Pediatr Nephrol; 2024 Feb; 39(2):603-607. PubMed ID: 37474629
[TBL] [Abstract][Full Text] [Related]
36. Is Plasma Exchange Efficacious in Shiga Toxin-Associated Hemolytic Uremic Syndrome? A Narrative Review of Current Evidence.
Keenswijk W; Raes A; De Clerck M; Vande Walle J
Ther Apher Dial; 2019 Apr; 23(2):118-125. PubMed ID: 30324646
[TBL] [Abstract][Full Text] [Related]
37. A hemolytic-uremic syndrome-associated strain O113:H21 Shiga toxin-producing Escherichia coli specifically expresses a transcriptional module containing dicA and is related to gene network dysregulation in Caco-2 cells.
Bando SY; Iamashita P; Guth BE; Dos Santos LF; Fujita A; Abe CM; Ferreira LR; Moreira-Filho CA
PLoS One; 2017; 12(12):e0189613. PubMed ID: 29253906
[TBL] [Abstract][Full Text] [Related]
38. Hemolytic uremic syndrome with mild renal involvement due to Shiga toxin-producing Escherichia coli (STEC) O145 strain.
Pérez L; Apezteguía L; Piñeyrúa C; Dabezies A; Bianco MN; Schelotto F; Varela G
Rev Argent Microbiol; 2014; 46(2):103-6. PubMed ID: 25011592
[TBL] [Abstract][Full Text] [Related]
39. Detection and characterization of circulating microvesicles containing Shiga toxin type 2 in a rat model of Hemolytic Uremic Syndrome.
Sacerdoti F; Gomez FD; Jancic C; Lombardo T; Pascuale CA; Moretton MA; Chiappetta DA; Ibarra C; Amaral MM
Toxicon; 2023 Dec; 236():107349. PubMed ID: 37979924
[TBL] [Abstract][Full Text] [Related]
40. Volume expansion mitigates Shiga toxin-producing E. coli-hemolytic uremic syndrome in children.
Böckenhauer J; Schild R; Kemper MJ; Henne T; Stein MV; Oh J; Loos S
Pediatr Nephrol; 2024 Jun; 39(6):1901-1907. PubMed ID: 38240870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
